Is Lamotrigine Tablet, Extended Release in shortage?
Lamotrigine Tablet, Extended Release is listed by FDA as being discontinued by at least one maker (updated Apr 29, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)
Discontinuation of the manufacture of the drug
Maker contact: 800-828-9393
- Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)
Discontinuation of the manufacture of the drug
Maker contact: 800-828-9393
- Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)
Discontinuation of the manufacture of the drug
Maker contact: 800-828-9393
- Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)
Discontinuation of the manufacture of the drug
Maker contact: 800-828-9393
- Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)
Discontinuation of the manufacture of the drug
Maker contact: 800-828-9393
- Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)
Discontinuation of the manufacture of the drug
Maker contact: 800-828-9393
Lamotrigine Tablet, Extended Release shortage questions
Is Lamotrigine Tablet, Extended Release in shortage?
Lamotrigine Tablet, Extended Release is listed by FDA as being discontinued by at least one maker (updated Apr 29, 2026).
What should I do if I can’t get Lamotrigine Tablet, Extended Release?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.